Prophylactic therapeutic plasma exchange in pregnant woman with Familial Chylomicronemia Syndrome - A case report

Transfus Apher Sci. 2022 Jun;61(3):103346. doi: 10.1016/j.transci.2021.103346. Epub 2021 Dec 15.

Abstract

Context: Familial Chylomicronemia Syndrome (FCS) is an inherited disease where lack of lipoprotein lipase results in severe hypertriglyceridemia that frequently leads to recurrent acute pancreatitis. Pregnancy in patients with familial chylomicronemia syndrome (FCS) post a risk for mother and baby with potential complications (pancreatitis, miscarriage and death). Therapeutic approach includes strict dietary measures and plasma exchange. Despite the development of new drugs for FCS, their safety in pregnancy has not yet been confirmed.

Case description: We present a case of a young, pregnant female with FCS who had miscarriage in the past during one episode of acute pancreatitis. Due to the inability to achieve lower TG levels with current therapy, from 27-th week of pregnancy we have started prophylactic therapeutic plasma exchange (two times per week). Patient was followed up until the delivery of a healthy baby boy and did not experience an episode of acute pancreatitis.

Conclusions: With adequate supervision and monitoring therapeutic plasma exchange represents a safe approach in pregnant women with FCS in order to reduce TGs and prevent pancreatitis. Therefore, we prevented potential complications for both mother and child.

Keywords: Familial chylomicronemia syndrome; Pancreatitis; Plasma exchange; Pregnancy.

Publication types

  • Case Reports

MeSH terms

  • Abortion, Spontaneous*
  • Acute Disease
  • Female
  • Humans
  • Hyperlipoproteinemia Type I* / drug therapy
  • Hyperlipoproteinemia Type I* / therapy
  • Male
  • Pancreatitis* / complications
  • Pancreatitis* / therapy
  • Plasma Exchange / adverse effects
  • Pregnancy
  • Pregnant Women

Supplementary concepts

  • Familial hyperchylomicronemia syndrome